Cargando…

SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma

BACKGROUND: SH3-containing guanine nucleotide exchange factor (SGEF), a RhoG-specific guanine nucleotide exchange factor (GEF), was consider as a key signal that determines cancer cell invasion. Although SGEF has been considered to highly express in glioma and prostate cancer. However, it is not wel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qian, Lu, Xiao, Liu, Quan-Xing, Zhou, Dong, Qiu, Yuan, Dai, Ji-Gang, Zheng, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816374/ https://www.ncbi.nlm.nih.gov/pubmed/29454349 http://dx.doi.org/10.1186/s12957-018-1331-8

Ejemplares similares

Tyrosine Phosphorylation of SGEF Regulates RhoG Activity and Cell Migration
por: Okuyama, Yusuke, et al.
Publicado: (2016)

The Guanine-Nucleotide Exchange Factor SGEF Plays a Crucial Role in the Formation of Atherosclerosis
por: Samson, Thomas, et al.
Publicado: (2013)

SGEF forms a complex with Scribble and Dlg1 and regulates epithelial junctions and contractility
por: Awadia, Sahezeel, et al.
Publicado: (2019)

Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration
por: Li, Yan-Qi, et al.
Publicado: (2021)

The Invasive Capacity of HPV Transformed Cells Requires the hDlg-Dependent Enhancement of SGEF/RhoG Activity
por: Krishna Subbaiah, Vanitha, et al.
Publicado: (2012)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

Prognostic and therapeutic potential of Adenylate kinase 2 in lung adenocarcinoma
por: Liu, Huibin, et al.
Publicado: (2019)

The PITX gene family as potential biomarkers and therapeutic targets in lung adenocarcinoma
por: Zhang, Chunyi, et al.
Publicado: (2021)

Plasmodium Circumsporozoite Protein Enhances the Efficacy of Gefitinib in Lung Adenocarcinoma Cells by Inhibiting Autophagy via Proteasomal Degradation of LC3B
por: Lu, Xiao, et al.
Publicado: (2022)

CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma
por: Liu, Xiaoling, et al.
Publicado: (2021)

Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma
por: Yang, Haoran, et al.
Publicado: (2019)

Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma
por: Wang, Kun, et al.
Publicado: (2022)

The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy
por: Lee, Hsiao-Chen, et al.
Publicado: (2022)

Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma
por: Dai, Hongshuang, et al.
Publicado: (2023)

Identification of EMT-Related lncRNAs as Potential Prognostic Biomarkers and Therapeutic Targets for Pancreatic Adenocarcinoma
por: Deng, Yanyao, et al.
Publicado: (2022)

Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma
por: Zheng, Xiangyu, et al.
Publicado: (2020)

Potential therapeutic targets of the nuclear division cycle 80 (NDC80) complexes genes in lung adenocarcinoma
por: Sun, Zhong-Yi, et al.
Publicado: (2020)

KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma
por: Li, Zhaodong, et al.
Publicado: (2021)

Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma
por: Christodoulou, Panayiota, et al.
Publicado: (2022)

RNA-Seq Analysis Identified XLOC_009190 as Potential Therapeutic Target for Lung Adenocarcinoma
por: Wang, Jing, et al.
Publicado: (2019)

Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

LINC02126 is a potential diagnostic, prognostic and immunotherapeutic target for lung adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2022)

Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma
por: Ding, Xiaoyan, et al.
Publicado: (2022)

Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma
por: Yuan, Yinjiao, et al.
Publicado: (2023)

Diagnostic and prognostic potential of the oral and gut microbiome for lung adenocarcinoma
por: Lim, Mi Young, et al.
Publicado: (2021)

Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis
por: Zhang, Jing, et al.
Publicado: (2021)

Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma
por: Li, Shuzhen, et al.
Publicado: (2021)

NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
por: Zhao, Cui, et al.
Publicado: (2021)

Prognostic and immunological potential of PPM1G in lung adenocarcinoma
por: Yin, Rongjiang, et al.
Publicado: (2023)

Cyclin genes as potential novel prognostic biomarkers and therapeutic targets in breast cancer
por: Liu, Nian-Qiu, et al.
Publicado: (2022)

The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target
por: Hu, Lei, et al.
Publicado: (2023)

5-mRNA-based prognostic signature of survival in lung adenocarcinoma
por: Xia, Qian-Lin, et al.
Publicado: (2023)

PINK1 Overexpression Promotes Cell Migration and Proliferation via Regulation of Autophagy and Predicts a Poor Prognosis in Lung Cancer Cases
por: Lu, Xiao, et al.
Publicado: (2020)

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection
por: Shen, Yu-Jia, et al.
Publicado: (2021)

Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
por: Ying, Junjie, et al.
Publicado: (2023)

DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma
por: Wu, Yang-Jie, et al.
Publicado: (2021)

hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma
por: Li, Shicheng, et al.
Publicado: (2018)

MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis
por: Luo, Wen-Zhao, et al.
Publicado: (2023)

The Significance of MMP-1 in EGFR-TKI–Resistant Lung Adenocarcinoma: Potential for Therapeutic Targeting
por: Saito, Ryoko, et al.
Publicado: (2018)

Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma
por: SUN, LU, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c0dk87m9hh0jmfg8vhjietdgl7